Long Non-Coding RNA in the Pathogenesis of Cancers
The incidence and mortality rate of cancer has been quickly increasing in the past decades. At present, cancer has become the leading cause of death worldwide. Most of the cancers cannot be effectively diagnosed at the early stage. Although there are multiple therapeutic treatments, including surgery, radiotherapy, chemotherapy, and targeted drugs, their effectiveness is still limited. The overall survival rate of malignant cancers is still low. It is necessary to further study the mechanisms for malignant cancers, and explore new biomarkers and targets that are more sensitive and effective for early diagnosis, treatment, and prognosis of cancers than traditional biomarkers and methods. Long non-coding RNAs (lncRNAs) are a class of RNA transcripts with a length greater than 200 nucleotides. Generally, lncRNAs are not capable of encoding proteins or peptides. LncRNAs exert diverse biological functions by regulating gene expressions and functions at transcriptional, translational, and post-translational levels. In the past decade, it has been demonstrated that the dysregulated lncRNA profile is widely involved in the pathogenesis of many diseases, including cancer, metabolic disorders, and cardiovascular diseases. In particular, lncRNAs have been revealed to play an important role in tumor growth and metastasis. Many lncRNAs have been shown to be potential biomarkers and targets for the diagnosis and treatment of cancers. This review aims to briefly discuss the latest findings regarding the roles and mechanisms of some important lncRNAs in the pathogenesis of certain malignant cancers, including lung, breast, liver, and colorectal cancers, as well as hematological malignancies and neuroblastoma.
Citations by journals
5
10
15
20
25
|
|
Frontiers in Genetics
|
Frontiers in Genetics
25 publications, 4.84%
|
Frontiers in Oncology
|
Frontiers in Oncology
21 publications, 4.06%
|
Pathology Research and Practice
|
Pathology Research and Practice
18 publications, 3.48%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
16 publications, 3.09%
|
Frontiers in Cell and Developmental Biology
|
Frontiers in Cell and Developmental Biology
13 publications, 2.51%
|
Cancer Cell International
|
Cancer Cell International
12 publications, 2.32%
|
BMC Cancer
|
BMC Cancer
10 publications, 1.93%
|
Cancers
|
Cancers
9 publications, 1.74%
|
Oncology Letters
|
Oncology Letters
8 publications, 1.55%
|
Molecular Medicine Reports
|
Molecular Medicine Reports
8 publications, 1.55%
|
Bioengineered
|
Bioengineered
8 publications, 1.55%
|
Journal of Oncology
|
Journal of Oncology
7 publications, 1.35%
|
Aging
|
Aging
7 publications, 1.35%
|
OncoTargets and Therapy
|
OncoTargets and Therapy
7 publications, 1.35%
|
Genes
|
Genes
6 publications, 1.16%
|
Frontiers in Molecular Biosciences
|
Frontiers in Molecular Biosciences
6 publications, 1.16%
|
Cell Death and Disease
|
Cell Death and Disease
6 publications, 1.16%
|
Cancer Management and Research
|
Cancer Management and Research
6 publications, 1.16%
|
Scientific Reports
|
Scientific Reports
5 publications, 0.97%
|
Disease Markers
|
Disease Markers
5 publications, 0.97%
|
PeerJ
|
PeerJ
4 publications, 0.77%
|
Bioscience Reports
|
Bioscience Reports
4 publications, 0.77%
|
Experimental and Therapeutic Medicine
|
Experimental and Therapeutic Medicine
4 publications, 0.77%
|
Translational Oncology
|
Translational Oncology, 4, 0.77%
Translational Oncology
4 publications, 0.77%
|
Clinica Chimica Acta
|
Clinica Chimica Acta
4 publications, 0.77%
|
Journal of Clinical Laboratory Analysis
|
Journal of Clinical Laboratory Analysis
4 publications, 0.77%
|
Biochemical Genetics
|
Biochemical Genetics
3 publications, 0.58%
|
Journal of Biomaterials and Tissue Engineering
|
Journal of Biomaterials and Tissue Engineering
3 publications, 0.58%
|
Biomedicines
|
Biomedicines
3 publications, 0.58%
|
5
10
15
20
25
|
Citations by publishers
10
20
30
40
50
60
70
80
90
100
|
|
Springer Nature
|
Springer Nature
98 publications, 18.96%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
78 publications, 15.09%
|
Elsevier
|
Elsevier
65 publications, 12.57%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
47 publications, 9.09%
|
Wiley
|
Wiley
35 publications, 6.77%
|
Spandidos Publications
|
Spandidos Publications
25 publications, 4.84%
|
Taylor & Francis
|
Taylor & Francis
25 publications, 4.84%
|
Hindawi Limited
|
Hindawi Limited
22 publications, 4.26%
|
Dove Medical Press
|
Dove Medical Press
18 publications, 3.48%
|
Impact Journals
|
Impact Journals
8 publications, 1.55%
|
Bentham Science
|
Bentham Science
7 publications, 1.35%
|
SAGE
|
SAGE
6 publications, 1.16%
|
Wolters Kluwer Health
|
Wolters Kluwer Health
5 publications, 0.97%
|
American Phytopathological Society
|
American Phytopathological Society
5 publications, 0.97%
|
AME Publishing Company
|
AME Publishing Company
5 publications, 0.97%
|
PeerJ
|
PeerJ
4 publications, 0.77%
|
Neoplasia Press
|
Neoplasia Press, 4, 0.77%
Neoplasia Press
4 publications, 0.77%
|
American Scientific Publishers
|
American Scientific Publishers
3 publications, 0.58%
|
Future Medicine
|
Future Medicine
3 publications, 0.58%
|
The Korean Society of Genetics
|
The Korean Society of Genetics, 3, 0.58%
The Korean Society of Genetics
3 publications, 0.58%
|
Walter de Gruyter
|
Walter de Gruyter
3 publications, 0.58%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
3 publications, 0.58%
|
Hans Publishers
|
Hans Publishers
3 publications, 0.58%
|
Mary Ann Liebert
|
Mary Ann Liebert
2 publications, 0.39%
|
Baishideng Publishing Group
|
Baishideng Publishing Group
2 publications, 0.39%
|
Public Library of Science (PLoS)
|
Public Library of Science (PLoS)
2 publications, 0.39%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
2 publications, 0.39%
|
IOS Press
|
IOS Press
2 publications, 0.39%
|
American Society for Clinical Investigation
|
American Society for Clinical Investigation
1 publication, 0.19%
|
10
20
30
40
50
60
70
80
90
100
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.